Collate
PrivateLast Round
Series C
Jun 3, 2026
Est. Valuation
$1B
Total Funding Raised
$105M
Company Overview
Collate is a healthtech company that develops AI tools to automate and streamline paperwork for diagnostic, medical device, and drug development companies.
Sector
AI, Data & Cloud Infrastructure
Verticals
Data Governance, Business Intelligence, NLP & Conversational AI, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Collate Comps
Public and private peers based on sector, stage, and business model.
Collate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 3, 2026 | ||||
| Series A | Jul 15, 2025 |
Collate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Conviction Partners | Series C |
| Karman Ventures | Series A |
| First Round Capital | Series C |
| Redpoint Ventures | Series C |
| Venrock | Series A |
| Unusual Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$95M raised, led by Redpoint Ventures.
- Jul 15, 2025
$10M round led by Venrock.
Collate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Collate's valuation, stock price, and market status.